Theriva Biologics, Inc.
TOVX
$1.42
$0.00780.55%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.91% | -47.34% | -51.55% | -49.38% | -44.53% |
| Total Receivables | 71.29% | 27.11% | 565.52% | 718.88% | 739.83% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.68% | -9.38% | -28.12% | -25.92% | -3.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -67.38% | -69.83% | -89.69% | -85.29% | -51.20% |
| Total Current Assets | -40.59% | -43.82% | -48.07% | -46.26% | -39.80% |
|
|
|||||
| Total Current Assets | -40.59% | -43.82% | -48.07% | -46.26% | -39.80% |
| Net Property, Plant & Equipment | -29.30% | -21.53% | -17.81% | -15.52% | 41.26% |
| Long-term Investments | -- | -- | -73.94% | -0.78% | 3.17% |
| Goodwill | -- | -- | -73.94% | -0.78% | 3.17% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.07% | -1.39% | -1.28% | -0.51% | 3.44% |
| Total Assets | -35.98% | -34.83% | -35.23% | -28.22% | -23.16% |
|
|
|||||
| Total Accounts Payable | 11.56% | -9.24% | 26.18% | 18.96% | -15.85% |
| Total Accrued Expenses | 0.00% | -26.45% | 53.94% | 46.50% | 55.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.09% | 15.21% | 10.79% | 11.33% | 101.47% |
| Total Finance Division Other Current Liabilities | 78.15% | 74.48% | -82.32% | -81.96% | -69.53% |
| Total Other Current Liabilities | 78.15% | 74.48% | -82.32% | -81.96% | -69.53% |
| Total Current Liabilities | 12.57% | -16.24% | -25.03% | -30.28% | -4.56% |
|
|
|||||
| Total Current Liabilities | 12.57% | -16.24% | -25.03% | -30.28% | -4.56% |
| Long-Term Debt | -43.21% | -34.67% | -39.22% | -0.63% | -26.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -39.46% | -33.05% | -31.00% | -27.91% | 21.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.73% | -2.84% | -1.25% | 6.27% | -18.68% |
| Total Liabilities | 4.92% | -12.39% | -16.68% | -15.57% | -10.26% |
|
|
|||||
| Common Stock & APIC | 2.59% | 2.60% | 1.01% | 0.82% | 0.81% |
| Retained Earnings | -8.29% | -8.78% | -7.41% | -6.44% | -6.31% |
| Treasury Stock & Other | -472.66% | 86.92% | -54.81% | -39.12% | 73.53% |
| Total Common Equity | -48.42% | -40.13% | -42.47% | -34.40% | -28.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -36.14% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -36.14% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -48.42% | -40.13% | -42.47% | -34.40% | -28.68% |
| Total Preferred Equity | -- | -- | -36.14% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -51.97% | -43.86% | -42.11% | -32.54% | -27.25% |
|
|
|||||